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INTRODUCTION 
 
The College of American Pathologists 
(CAP) established a revised set of 
recommendations for placental 
evaluation in 1997.  In review of the 
literature and anecdotally, there is 
discrepancy regarding placental 
submission to pathology.  We evaluated 
adherence to CAP guidelines for 
placental pathology and clinical utility of 
the results. 
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METHODS 
 
Retrospective case review of deliveries 
performed at the University of Iowa from 
January 1 through March 1, 2005.  
Results were categorized as reviewed 
(met CAP guidelines and sent to 
pathology), not reviewed (met CAP 
guidelines and not sent to pathology), 
and not indicated (did not meet CAP 
guidelines and sent to pathology).   
 
RESULTS 
 
Of 251 deliveries, 113 placentas were 
evaluated pathologically.  56 met criteria 
for evaluation and were sent to 
pathology.  54 met criteria and were not 
sent to pathology.  Three did not meet 
criteria and were evaluated.  PPROM 
(25%) and preeclampsia (19.6%) were 
the two highest clinical indications in 
which placentas were sent for 
evaluation.  Pathological costs for 
reviewed group of placentas were 
$32,406.  Projected costs for those 
placentas not reviewed but meeting 
CAP guidelines were $34,567.  77 
deliveries were performed via cesarean 
section.  Cesarean deliveries 
(n=36[63%]) were evaluated more 
frequently than vaginal deliveries 
(n=18[32%]) when CAP guidelines were 
met.  Vaginal deliveries (n=27[52%]) 
were less likely to be evaluated as 
compared to cesarean deliveries 
(n=13[25%]) when CAP guidelines were 
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met.  Only one placenta pathology result 
(IUFD) was documented at the 
postpartum visit.  There was no follow-
up documentation identified for the 
remaining placentas evaluated 
pathologically.   
 
CONCLUSIONS 
 
It appears that providers do not follow a 
uniform set of criteria when submitting 
placentas for evaluation.  Providers are 
more-likely to send placentas following 
cesarean section despite meeting CAP 
indication.  There appears to be minimal 
clinical utility from pathological 
evaluation given lack of postpartum 
documentation.   
 
 
